U.S. markets open in 8 hours 1 minute
  • S&P Futures

    4,271.00
    -10.00 (-0.23%)
     
  • Dow Futures

    33,646.00
    -72.00 (-0.21%)
     
  • Nasdaq Futures

    13,542.50
    -35.25 (-0.26%)
     
  • Russell 2000 Futures

    2,010.80
    -6.10 (-0.30%)
     
  • Crude Oil

    91.20
    -0.89 (-0.97%)
     
  • Gold

    1,809.50
    -6.00 (-0.33%)
     
  • Silver

    20.60
    -0.09 (-0.45%)
     
  • EUR/USD

    1.0251
    -0.0006 (-0.06%)
     
  • 10-Yr Bond

    2.8490
    0.0000 (0.00%)
     
  • Vix

    19.53
    -0.67 (-3.32%)
     
  • GBP/USD

    1.2116
    -0.0023 (-0.19%)
     
  • USD/JPY

    133.2360
    -0.2440 (-0.18%)
     
  • BTC-USD

    24,848.53
    +282.96 (+1.15%)
     
  • CMC Crypto 200

    592.11
    +20.82 (+3.65%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,870.51
    +323.53 (+1.13%)
     

U.S. orders another 2.5 mln doses of Bavarian Nordic's monkeypox vaccine

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

July 15 (Reuters) - The U.S. government has ordered another 2.5 million doses of Bavarian Nordic's vaccine for use against monkeypox, the Danish vaccine maker said on Friday.

The vaccine, Jynneos, is cleared in the United States for the prevention of smallpox and monkeypox disease among adults.

The United States had ordered 500,000 doses of the vaccine in June, followed by another 2.5 million earlier this month, as it ramps up its fight against a global outbreak of the viral disease which causes flu-like symptoms and skin lesions.

Around 60 countries in which monkeypox is not endemic have reported outbreaks of the viral disease, with confirmed cases crossing 11,500.

(Reporting by Amruta Khandekar; Editing by Devika Syamnath)